Effects of atomoxetine treatment in humans.
Phase of Trial: Phase I/II
Latest Information Update: 07 Aug 2018
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder; Parkinson's disease
- Focus Pharmacodynamics
- 24 Sep 2010 Actual end date (September 2009) added as reported by ClinicalTrials.gov.
- 24 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Mar 2008 New trial record.